Abstract

Beneficial efficacy for type 2 diabetes (T2D) and Metabolic syndrome (Met-S) by vildagliptin/metformin (EquMet)

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Additive effects of type 2 diabetes and metabolic syndrome on left ventricular torsion and linear deformation abnormalities during dobutamine stress echocardiography.
Falah Aboukhoudir ... Antoine Grandperrin
Frontiers in Cardiovascular Medicine | VOL. 9
Falah Aboukhoudir, et. al.Falah Aboukhoudir ... Antoine Grandperrin
08 Sep 2022
Controlled clinical trial with the combination therapy with metformin, thiazolidinediones, glucagon-like peptide 1 analog in patients with type 2 diabetes and metabolic syndrome
...
Chinese Journal of Endocrinology and Metabolism | VOL. 35
, et. al. ...
25 Sep 2019
An Evidence-Based Review of Exercise and Metabolic Syndrome
James R Churilla
Journal of Clinical Exercise Physiology | VOL. 1
James R ChurillaJames R Churilla
01 Mar 2012
Double diabetes: the cardiovascular implications of combining type 1 with type 2 diabetes
Steve Cleland
Practical Diabetes International | VOL. 34
Steve ClelandSteve Cleland
01 Jul 2017
View more papers

More From: International Journal of Endocrinology and Diabetes

Paper Title
Journal
Date
Author
-
-
International Journal of Endocrinology and Diabetes | VOL. -
--
20 Jul 2024
Metabolic Syndrome and Pre-Metabolic Syndrome among Health Care Workers in Yemen: Prevalence and Associated Risk Factors
-
International Journal of Endocrinology and Diabetes | VOL. -
--
20 Jul 2024
-
-
International Journal of Endocrinology and Diabetes | VOL. 7
--
18 Jun 2024
Diabetic remission incidence related with weight reduction and effective treatment
-
International Journal of Endocrinology and Diabetes | VOL. 7
--
18 Jun 2024
View more papers